当前位置: 首页 > 期刊 > 《世界中医药》 > 20176
编号:13617285
史大卓教授治疗急性心肌梗死的中医临床经验(4)
http://www.100md.com 2017年3月15日 《世界中医药》 20176
     [11]Ritsinger V,Saleh N,Lagerqvist B,et al.High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus:results from the Swedish coronary angiography and angioplasty registry[J].Circ Cardiovasc Interv,2015,8(6):e002328.

    [12]郑成斌.冠状动脉支架植入术后支架内再狭窄相关因素的Meta分析[D].太原:山西医科大学,2016.

    [13]D′Ascenzo F,Bollati M,Clementi F,et al.Incidence and predictors of coronary stent thrombosis:evidence from an international collaborative meta-analysis including 30 studies,221,066 patients,and 4276 thromboses[J].Int J Cardiol,2013,167(2):575-584.

    [14]Brodie B,Pokharel Y,Fleishman N,et al.Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction:a 15-year single-center experience[J].JACC Cardiovasc Interv,2011,4(1):30-38.

    [15]Niccoli G,Burzotta F,Galiuto L,et al.Myocardial no-reflow in humans[J].J Am Coll Cardiol,2009,54(4):281-292.

    [16]史大卓,徐浩,殷惠軍,等.“瘀”、“毒”从化——心脑血管血栓性疾病病因病机[J].中西医结合学报,2008,6(11):1105-1108.

    [17]黄群,冷玉杰.四妙勇安汤治疗血管闭塞性脉管炎的临床中药学研究[J].中医药信息,2016,33(5):73-77.

    (2017-03-03收稿 责任编辑:张文婷), http://www.100md.com(张璇 王培利 柴华)
上一页1 2 3 4